Tampa Firm Warned for Investigational, Procedural Issues

The FDA warned Clover Custom Blending after an investigation of its Tampa, Florida-based manufacturing plant revealed uninvestigated out-of-specification results, missing written procedures and other deficiencies.
Source: Drug Industry Daily